.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Spotlight

The OncLive Insider app is live!
CME Opportunities

SpecialtySee All >

Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer

Advertise
About OncLive
Editorial Board
MJH Life Sciences brands
Contact Us
Privacy
Terms & Conditions
Do Not Sell My Information

2 Clarke Drive
Suite 100
Cranbury, NJ 08512

New Paradigms for Treatment of Locally Advanced NSCLC

EP. 1: New Paradigms for Treatment of Locally Advanced NSCLC

March 13th 2018

EP. 2: Locally Advanced NSCLC: Treatment Goals and Challenges

March 13th 2018

EP. 3: Key Considerations in the Management of Stage 3 NSCLC

March 13th 2018

EP. 4: Locally Advanced NSCLC: Treatment Overview

March 13th 2018

EP. 5: PACIFIC Trial: A Game Changer in Unresectable LA NSCLC

March 13th 2018

EP. 6: Chemotherapy Choices in the PACIFIC Trial

March 13th 2018

EP. 7: NSCLC: Consolidation Immunotherapy in Practice

March 13th 2018

EP. 8: Tips for Managing NSCLC Patients on Durvalumab Therapy

March 13th 2018

EP. 9: Improving Care in Locally Advanced NSCLC

March 13th 2018

EP. 10: Promising Developments in Locally Advanced NSCLC

March 13th 2018

EP. 11: Locally Advanced NSCLC: Audience Q&A

March 13th 2018